表紙
市場調查報告書

末梢神經刺激設備 (PNS):醫療設備的開發平台評估

Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 920906
出版日期 內容資訊 英文 34 Pages
訂單完成後即時交付
價格
Back to Top
末梢神經刺激設備 (PNS):醫療設備的開發平台評估 Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月24日內容資訊: 英文 34 Pages
簡介

本報告提供全球末梢神經刺激設備 (PNS) 市場上之主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,同時彙整產品特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (資本交易·事業聯盟等) 等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 末梢神經刺激設備 (PNS):各企業現在臨床實驗中的開發中產品

  • 末梢神經刺激設備的企業:各臨床實驗階段的開發中產品
  • 末梢神經刺激設備:各臨床實驗階段的開發中產品

第5章 末梢神經刺激設備 (PNS)的企業·產品概要

  • Aachen Resonance GmbH
    • 開發中產品及進行中的臨床實驗概要
  • Cardionomic Inc (Inactive)
  • Checkpoint Surgical Inc
  • EMKinetics, Inc.
  • Epineuron Technologies Inc
  • Gondola Medical Technologies SA
  • Remedee Labs SAS
  • Washington University School of Medicine

第6章 末梢神經刺激設備 (PNS) 市場:目前的趨勢 (全7件)

第7章 附錄

目錄
Product Code: GDME0901EPD

GlobalData's Medical Devices sector report, "Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2019" provides an overview of Peripheral Nerve Stimulators (PNS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Nerve Stimulators (PNS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Peripheral Nerve Stimulators (PNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Nerve Stimulators (PNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Nerve Stimulators (PNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 3
  • 1.2 List of Figures 3

2 Introduction 4

  • 2.1 Peripheral Nerve Stimulators (PNS) Overview 4

3 Products under Development 5

  • 3.1 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 5
  • 3.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory 6
  • 3.3 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path 7
  • 3.4 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date 8
  • 3.5 Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials 9

4 Peripheral Nerve Stimulators (PNS) - Pipeline Products under Development by Companies 10

  • 4.1 Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development 10
  • 4.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 11

5 Peripheral Nerve Stimulators (PNS) Companies and Product Overview 12

  • 5.1 Actuated Medical Inc Company Overview 12
    • 5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 12
  • 5.2 Cardionomic Inc (Inactive) Company Overview 13
    • 5.2.1 Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.3 Checkpoint Surgical Inc Company Overview 14
    • 5.3.1 Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.4 EMKinetics, Inc. Company Overview 15
    • 5.4.1 EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.5 Epineuron Technologies Inc Company Overview 18
    • 5.5.1 Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.6 Gondola Medical Technologies SA Company Overview 19
    • 5.6.1 Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.7 Remedee Labs SAS Company Overview 22
    • 5.7.1 Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.8 Washington University School of Medicine Company Overview 25
    • 5.8.1 Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 25

6 Peripheral Nerve Stimulators (PNS)- Recent Developments 26

  • 6.1 Nov 13, 2019: Remedee Labs Breakthrough Endorphin Stimulation Solution Is Unveiled 26
  • 6.2 Nov 13, 2019: New clinical trial into pain management started by leading French research hospital 26
  • 6.3 Sep 23, 2019: Cala Health announces positive topline data from landmark PROSPECT study for essential tremor (ET) 26
  • 6.4 Aug 21, 2019: SPR Therapeutics SPRINT Peripheral Nerve Stimulation System significantly reduces opioid use in patients with low back pain, interim data show 27
  • 6.5 Apr 08, 2019: Study of SPR Therapeutics Peripheral Nerve Stimulation System demonstrates significant and sustained relief of post-amputation pain 28
  • 6.6 Jan 17, 2019: Cala Health enrolls first patients in landmark PROSPECT study for essential tremor 29
  • 6.7 Jan 15, 2019: SPR Therapeutics names Dr. Peter Staats as Chief Medical Advisor 30

7 Appendix 31

  • 7.1 Methodology 31
  • 7.2 About GlobalData 34
  • 7.3 Contact Us 34
  • 7.4 Disclaimer 34

List of Tables

  • Table 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 5
  • Table 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory 6
  • Table 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path 7
  • Table 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date 8
  • Table 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials 9
  • Table 6: Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development 10
  • Table 7: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 11
  • Table 8: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 12
  • Table 9: Peripheral Nerve Targeting System - Product Status 12
  • Table 10: Peripheral Nerve Targeting System - Product Description 12
  • Table 11: Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 12: Neurostimulator - Cardiac Contractility - Product Status 13
  • Table 13: Neurostimulator - Cardiac Contractility - Product Description 13
  • Table 14: Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 15: Checkpoint BEST System - Product Status 14
  • Table 16: Checkpoint BEST System - Product Description 14
  • Table 17: EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 18: TranStim Transdermal Neuromodulation System - Product Status 15
  • Table 19: TranStim Transdermal Neuromodulation System - Product Description 15
  • Table 20: EMKinetics, Inc. - Ongoing Clinical Trials Overview 16
  • Table 21: TranStim Transdermal Neuromodulation System - Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home 17
  • Table 22: Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 23: Wearable Device - Peripheral Nerve Stimulation - Product Status 18
  • Table 24: Wearable Device - Peripheral Nerve Stimulation - Product Description 18
  • Table 25: Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 26: Gondola Device - Product Status 19
  • Table 27: Gondola Device - Product Description 19
  • Table 28: Gondola Medical Technologies SA - Ongoing Clinical Trials Overview 20
  • Table 29: Gondola Device - Multi-center, Double-blind, Cross-over Randomized Study on the Use of the Medical Device Gondola for Motor Rehabilitation in Patients with Parkinson's Disease 21
  • Table 30: Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 31: Endorphin-Stimulation Device - Product Status 22
  • Table 32: Endorphin-Stimulation Device - Product Description 22
  • Table 33: Remedee Labs SAS - Ongoing Clinical Trials Overview 23
  • Table 34: Endorphin-Stimulation Device - Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer: First in Human Evaluation in Perioperative with Regard to a Control Group 24
  • Table 35: Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 36: Biodegradable Device - Electrical Stimulation - Product Status 25
  • Table 37: Biodegradable Device - Electrical Stimulation - Product Description 25
  • Table 38: Glossary 33

List of Figures

  • Figure 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 5
  • Figure 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory 6
  • Figure 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path 7
  • Figure 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date 8
  • Figure 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials 9
Back to Top